Platelet-predominate gene expression and reticulated platelets in nonvalvular atrial fibrillation: Effect of pulmonary veins isolation

J Cardiovasc Electrophysiol. 2018 Mar;29(3):412-420. doi: 10.1111/jce.13438. Epub 2018 Feb 13.

Abstract

Introduction: Reticulated platelet (RP) content is increased in nonvalvular atrial fibrillation (NVAF). The purpose of this study was to determine if platelet content, morphology, and RP proportion are modulated by platelet genes.

Methods and results: Expression of six platelet-predominate genes impacting platelet formation and release, platelet count, and RP content was assessed in NVAF patients before and 3-4 months after pulmonary veins isolation (PVI) and compared to normal sinus rhythm (NSR) controls. RNA from isolated platelets was reverse-transcribed assayed against selected genes utilizing real-time qPCR, and expressed as mean cycle threshold (ΔCt) using beta-2-microglobulin as endogenous control. RP content was assessed by flow cytometry. A fourfold lower expression of CFL1 gene coding for nonmuscle cofilin (7.8 ± 0.9 vs. 5.7 ± 1.6, P < 0.001) and twofold lower expression of four other genes were associated with similar platelet counts but fourfold higher (28.7+7.0 vs. 6.7+5.4, P < 0.001) RP content (%) in 97 NVAF cases compared to 51 NSR controls. Three to 4 months after PVI, RP decreased by 28%, while CFL1 gene expression increased over twofold but TUBA4A gene expression decreased almost twofold; NFE2 and MYL6 gene expression remained unchanged.

Conclusions: NVAF is associated with notable downregulation of genes directing platelet production and size but increased RP content. PVI impacts the expression of many of these genes, implying a direct relationship between atrial fibrillation and platelet biogenesis.

Keywords: atrial fibrillation; gene expression; reticulated platelets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Aged
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / surgery*
  • Blood Platelets / metabolism*
  • Blood Platelets / pathology
  • Case-Control Studies
  • Catheter Ablation* / adverse effects
  • Cofilin 1 / blood
  • Cofilin 1 / genetics
  • Female
  • Gene Expression Regulation
  • Heart Rate
  • Humans
  • Male
  • Membrane Proteins / blood
  • Membrane Proteins / genetics
  • Middle Aged
  • Myosin Light Chains / blood
  • Myosin Light Chains / genetics
  • NF-E2 Transcription Factor, p45 Subunit / blood
  • NF-E2 Transcription Factor, p45 Subunit / genetics
  • Platelet Count
  • Pulmonary Veins / physiopathology
  • Pulmonary Veins / surgery*
  • Receptors, Progesterone / blood
  • Receptors, Progesterone / genetics
  • Time Factors
  • Treatment Outcome
  • Tubulin / blood
  • Tubulin / genetics

Substances

  • CFL1 protein, human
  • Cofilin 1
  • Membrane Proteins
  • Myosin Light Chains
  • NF-E2 Transcription Factor, p45 Subunit
  • NFE2 protein, human
  • PDZK1IP1 protein, human
  • PGRMC1 protein, human
  • Receptors, Progesterone
  • Tubulin